Introduction
Epilepsy is a chronic condition that causes great impact in patient's quality of life and on the health care budget. Its prevalence is approximately 0.5-1% in general population. 1 In developing countries, the incidence and prevalence rates are higher due to the high proportion of young individuals and their hygiene and public health conditions. 2 Twenty percent of the epilepsies are medically intractable and mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS) has been recognized as a well-defined surgically remediable epileptic syndrome. [3] [4] [5] The adequate selection of these patients for surgery depends on the concordance of clinical, neuroimaging and electroencephalographic (EEG) data. 4 Few abnormalities may be found on general neurologic interview and examination other than the seizures among MTLE-HS patients, as facial asymmetry with lower facial weakness contralateral to HS. 6 These symptoms or signs may be a clinically useful clue that may assist in lateralizing the site of seizure onset, aiding in the presurgical selection of these patients. The association between epilepsy and headache is still poorly understood although it has been recognized for a long time. 7 Both migraine and epilepsy are chronic neurological disorders manifested as paroxysmal episodes of transient brain dysfunction with clinical characteristic symptoms often including gastrointestinal and autonomic manifestations, postictal lethargy, altered level of consciousness, visual disturbances, hormonal involvement, dizziness, numbness, hemiparesis and aphasia. [7] [8] [9] Welch et al. 10 proposed that an altered excitability status of occipital cortex may be an important pathogenic factor for migraine, probably lowering the threshold for the development of cortical spreading depression (CSD). Moreover, experimentally induced CSD in human neocortical slices was able to induce sharp potentials, 11 representing a possible link between migraine and epilepsy. We investigated the prevalence, clinical patterns and lateralizing value of headache in a well-defined and homogeneous group of MTLE-HS patients.
Methods
This was an observational, cross-sectional and analytic study. From May 2009 to April 2010, we interviewed all MTLE-HS patients undergoing presurgical evaluation in Centro de Epilepsia de Santa Catarina (CEPESC), Florianó polis, SC, Brazil, due to refractory epilepsy.
The comprehensive presurgical evaluation consisted of a detailed clinical history, neurologic examination, cerebral 1.5 T magnetic resonance imaging (MRI), neuropsychological and psychiatric studies, and psychosocial assessments. Patients also underwent 2-6 days of continuous video-EEG monitoring with 32-channel EEG recording, with electrodes placed according to 10-10 system on the temporal lobes. All patients had clear MRI findings consistent with HS and concordant interictal and ictal EEG data. Hippocampal sclerosis was defined if atrophy, an increased T2-weighted signal, a decreased T1-weighted signal, and disrupted internal structure of the hippocampus were present on visual inspection of MRI pictures. [12] [13] [14] The epileptogenic zone was determined by predominantly ipsilateral interictal epileptic abnormalities (70% cutoff) and unequivocal unilateral seizure onset recorded during prolonged video-EEG monitoring. Clinical features were recorded according to a specific protocol developed for this study. Patients' previous medical charts were also reviewed. The exclusion criteria [15] [16] [17] were: (1) focal neurological abnormalities on physical examination suggesting a constellation other than MTLE-HS; (2) generalized or extratemporal EEG spikes; (3) marked cognitive impairment on neuropsychological testing suggesting a more widespread disease other than MTLE-HS and subject to compromising the interview. A standardized questionnaire was applied according to the criteria of the International Headache Society (IHS) by one researcher (DBZ) blinded for all the clinical, radiological and EEG data of patients. Ten percent of these interviews were also applied in the same patient by the first author (JCN) to assure the reproducibility of the questionnaire. Headache diagnosis was made by a board certified neurologist (JCN) based on the second edition of the International Classification of Headache Disorders (ICHD-II), 18 according to the headache episodes presented in the previous year. Patients were divided into two groups: (1) migraine patients and (2) tension-type headache (TTH) patients. The headache diagnosis was blinded for all the clinical, radiological and EEG data related to the epileptic syndrome including the MRI findings. Clinical and demographic characteristics included age, gender and schooling. The use of sodium valproate was also controlled due to its effect on headache prophylaxis. Regarding headaches, the following features were analyzed: presence of headache episodes in lifetime and in the previous year; frequency; age of onset; pattern; predominant side; severity (assessed using an analogical scale: 0-10; 0, no pain and 10, worst possible pain); duration; associated symptoms and symptomatic medicines used during the events. For those patients presenting more than one type of headache, the most severe and troublesome type was taken into consideration for this study. According to the temporal relation between headaches and seizures, headache was classified as interictal (non-temporal relation) and peri-ictal (well-established temporal association). Some patients referred both, but the peri-ictal type was the only one considered for the analysis of its lateralizing value in relation to HS.
This study was approved by the Ethics Committee on Human's Research of our hospital and informed consent was obtained from all patients.
Statistical analysis
Statistical analysis was performed using the SPSS for Windows 17.0 (SPSS Inc., Chicago, IL, USA).
Categorical variables were analyzed by Fisher's exact test. Continuous variables were analyzed by Student's t-test (parametric distribution) or Mann-Whitney U-test (non-parametric distribution) accordingly. Posteriorly, continuous variables were categorized in order to allow analysis of the association between the headache type and clinical, demographic and neuroimaging variables by binary logistic regression. Also, the association between the side of HS and unilateral headache was analyzed by binary multiple logistic regression. The association between the age of epilepsy onset (age of recurrent seizures) and the age of headache onset was analyzed by simple linear regression.
The ''p'' levels lower than 0.01 were considered significant. This more stringent criterion for the ''p'' level of significance was based on the Bonferroni adjustment for multiple tests. 19 
Results
A hundred consecutive patients were interviewed. Their median age was 38 (29-45) years and 55 (55%) were female.
Clinical and demographic variables according to the presence of headache are demonstrated in Table 1 . Headache episodes were referred by 92 (92%) of all patients and they were classified according to ICHD-II. 18 There were no statistical differences concerning gender, age of first epileptic seizure, frequency of seizures and MRI findings between patients with and without headache (p > 0.32). There was a non-significant trend for lower age of epilepsy onset (p = 0.12) and longer duration of epilepsy (p = 0.19) among patients presenting headache.
The most frequent diagnosis was migraine without aura in 24 patients (24%) followed by probable migraine in 19 (19%). Furthermore, infrequent episodic TTH was diagnosed in 15 (15%) and migrainous-type chronic daily headache (CDH) in 8 (8%) patients.
The association among the type of headache, clinical, demographic and neuroimaging data as well as headache severity and frequency are presented in Table 2 . The Crude Odds Ratio indicates the level of association between the analyzed variables and migrainous headache. Migraine occurred in 51.9% while TTH in 39.1% patients. As expected, patients with migraine had higher frequency (p < 0.006), duration (p < 0.02), severity (p < 0.001) and lateralized pain (p < 0.002) than TTH ones. In comparison to interictal headache, peri-ictal headache was 3.9 times more associated to migraine than TTH (OR 3.9; CI 95% 1.4-11.2; p = 0.01). There were no statistical differences concerning the (Table 3) .
Discussion
This study showed a higher prevalence of headache among MTLE-HS patients (92%) in comparison to the 80.8% in the general population of our city previously reported in an epidemiological study. 20 Other studies have attempted to demonstrate an association between epilepsy and headaches. Headache episodes were associated with the occurrence of seizures in 15-62% of patients with epilepsy, in which 55% were of migrainous-type and 37% tension-type, being 34-60% exclusively peri-ictal. [21] [22] [23] [24] Our prevalence was higher than previously reported, probably related to higher frequency of seizures and duration/severity of epilepsy of our patient population, selected from a tertiary health care center. Among patients with unilateral HS, we evidenced a significant association between the predominant side of headache and the side of HS. Our findings are in agreement with other studies, which demonstrated association between the headache lateralization and seizure onset zone in patients with temporal lobe epilepsy. 25 Our study also provided evidence for the possible relation between headache and epilepsy by demonstrating the temporal association between the seizure frequency and headache episodes. Our findings may have implications in the current knowledge of the headache pathophysiology. Despite the fact that the association between epilepsy and headache has already been discussed for many years, its pathophysiology remains obscure. There seems to be an agreement regarding the side of headache and HS, which would suggest a common underlying brain dysfunction. In fact, the most frequently accepted mechanism for the relation between vascular and neuronal function in migraine aura is the CSD described by Leão. 26 CSD consists of a wave of cortical hyperarousal followed by an inhibitory wave, which is evidenced by the reduction of 15-53% of cerebral blood flow during visual auras in occipital cortex contralateral to the affected visual field. Interestingly, only one of our patients presented migraine with aura. After the binary multiple logistic regression analysis we demonstrated an association between the HS and predominant headache side which remained significant, independently of the type of headache (migraine Â TTH). The epilepsy surgery enables the direct visualization of cortical vessel vasodilation during an epileptic attack. It has also been extensively documented by ictal Single Photon Emission Computed Tomography (SPECT). 27 Nitric oxide (NO) is involved in the regulation of basal cerebral circulation during hypercapnia, neuronal activation and ictal brain vasodilation. 28 The NO is an important neurotransmitter in the glutamatergic excitatory synapses 29 which may be the common link related with the neuronal hyperactivity and brain hyperperfusion during epileptic seizures and headache episodes. 30 There are some limitations that need to be acknowledged regarding the present study. The first one concerns the crosssectional design and the second one concerns the frequency of headache episodes, which was based on retrospective recall by the patient. We tried to avoid this recall bias by taking into account only the headache episodes occurred within the last year.
Furthermore, the findings in our study may not be applied to all epilepsy patients due to the fact that it included only refractory patients from a tertiary health care center.
In conclusion, physicians should be familiar with the principles of the diagnosis and treatment of both epilepsy and headache. Specific strategies must be applied to both comorbidities once they are often seen in association. Further prospective, placebocontrolled, double-blind and randomized studies are required to determine the best therapeutic strategy to treat headache in patients with epilepsy.
